Edvardas Danila

1.4k total citations
48 papers, 350 citations indexed

About

Edvardas Danila is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Edvardas Danila has authored 48 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 11 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Edvardas Danila's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Tuberculosis Research and Epidemiology (9 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Edvardas Danila is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Tuberculosis Research and Epidemiology (9 papers) and Sarcoidosis and Beryllium Toxicity Research (7 papers). Edvardas Danila collaborates with scholars based in Lithuania, France and United Kingdom. Edvardas Danila's co-authors include Edvardas Žurauskas, Rolandas Zablockis, Vytautas Kasiulevičius, Mindaugas Balčiūnas, Jelena Čelutkienė, Saulius Diktanas, Giedrė Smailytė, Saulius Cicėnas, Rūta Aldonytė and Edvardas Bagdonas and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Respiratory Journal.

In The Last Decade

Edvardas Danila

44 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edvardas Danila Lithuania 11 207 140 66 65 49 48 350
Pernilla Darlington Sweden 10 284 1.4× 312 2.2× 54 0.8× 27 0.4× 22 0.4× 20 386
Teyfik Turgut Türkiye 11 142 0.7× 112 0.8× 82 1.2× 97 1.5× 73 1.5× 25 360
Ruchi Dua India 9 118 0.6× 85 0.6× 28 0.4× 23 0.4× 85 1.7× 38 316
Serir Aktoğu Türkiye 9 384 1.9× 153 1.1× 92 1.4× 90 1.4× 177 3.6× 31 550
S. Della Valle Italy 9 79 0.4× 88 0.6× 114 1.7× 13 0.2× 115 2.3× 17 365
K. McManus United Kingdom 12 182 0.9× 54 0.4× 21 0.3× 98 1.5× 262 5.3× 24 400
Miguel Park United States 8 70 0.3× 105 0.8× 39 0.6× 25 0.4× 26 0.5× 22 351
Víctor del Campo-Pérez Spain 8 76 0.4× 52 0.4× 32 0.5× 52 0.8× 24 0.5× 23 252
Brunilda Marku Italy 8 311 1.5× 384 2.7× 119 1.8× 33 0.5× 39 0.8× 11 564
Ahmed Fahim United Kingdom 10 199 1.0× 79 0.6× 27 0.4× 10 0.2× 28 0.6× 44 276

Countries citing papers authored by Edvardas Danila

Since Specialization
Citations

This map shows the geographic impact of Edvardas Danila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edvardas Danila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edvardas Danila more than expected).

Fields of papers citing papers by Edvardas Danila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edvardas Danila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edvardas Danila. The network helps show where Edvardas Danila may publish in the future.

Co-authorship network of co-authors of Edvardas Danila

This figure shows the co-authorship network connecting the top 25 collaborators of Edvardas Danila. A scholar is included among the top collaborators of Edvardas Danila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edvardas Danila. Edvardas Danila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danila, Edvardas, et al.. (2025). The Lithuanian Lung Cancer Screening Model: Results of a Pilot Study. Cancers. 17(12). 1956–1956. 1 indexed citations
2.
Armalytė, Julija, Edvardas Danila, Daiva Bironaitė, et al.. (2024). Insights into respiratory microbiome composition and systemic inflammatory biomarkers of bronchiectasis patients. Microbiology Spectrum. 12(12). e0414423–e0414423. 2 indexed citations
3.
Armalytė, Julija, Edvardas Danila, Daiva Bironaitė, et al.. (2024). Human nasal microbiota shifts in healthy and chronic respiratory disease conditions. BMC Microbiology. 24(1). 150–150. 13 indexed citations
4.
Centis, Rosella, Lia D’Ambrosio, Jan‐Willem C. Alffenaar, et al.. (2023). Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study. International Journal of Infectious Diseases. 130. S25–S29. 20 indexed citations
5.
6.
Davidavičienė, Edita, et al.. (2023). The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis. PLoS ONE. 18(3). e0282046–e0282046. 6 indexed citations
7.
Jurevičienė, Elena, Vytautas Kasiulevičius, Edita Kazėnaitė, et al.. (2022). Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis. International Journal of Environmental Research and Public Health. 19(2). 970–970. 8 indexed citations
8.
Danila, Edvardas, et al.. (2020). A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer. International Journal of Environmental Research and Public Health. 17(5). 1747–1747. 2 indexed citations
9.
Danila, Edvardas, et al.. (2020). Lung Cancer in Lithuania. Journal of Thoracic Oncology. 15(9). 1401–1405. 1 indexed citations
10.
Danila, Edvardas, et al.. (2020). Prognostic value of Mastora obstruction score in acute pulmonary embolism. SHILAP Revista de lepidopterología. 26(4). 191–198. 2 indexed citations
11.
Kasiulevičius, Vytautas, et al.. (2019). Diagnosing COPD in primary care: what has real life practice got to do with guidelines?. Multidisciplinary Respiratory Medicine. 14(1). 28–28. 22 indexed citations
12.
Zablockis, Rolandas, et al.. (2018). Prognostic Value of Thyroid Transcription Factor-1 Expression in Patients with Advanced Lung Adenocarcinoma. In Vivo. 32(6). 1571–1579. 4 indexed citations
13.
Altraja, Alan, А. S. Belevskiy, Piotr Boros, et al.. (2017). Inhaled therapies in patients with moderate COPD in clinical practice: current thinking. International Journal of COPD. Volume 13. 45–56. 13 indexed citations
14.
Čelutkienė, Jelena, et al.. (2017). Challenges of Treating Acute Heart Failure in Patients with Chronic Obstructive Pulmonary Disease. Cardiac failure review. 3(1). 56–56. 28 indexed citations
15.
Danila, Edvardas, et al.. (2014). Clinical significance of C reactive protein and MASTORA score in pulmonary embolism. European Respiratory Journal. 44(Suppl 58). P3659–P3659. 1 indexed citations
16.
Danila, Edvardas, et al.. (2009). Manifestation peculiarities of idiopathic chronic eosinophilic pneumonia. Open Medicine. 5(1). 75–82.
17.
Danila, Edvardas, et al.. (2009). BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity. Upsala Journal of Medical Sciences. 114(1). 26–31. 23 indexed citations
18.
Danila, Edvardas, et al.. (2008). BAL fluid cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosi. Advances in Medical Sciences. 53(2). 228–33. 25 indexed citations
19.
Danila, Edvardas, et al.. (2008). Significance of bronchoscopic lung biopsy in clinical practice. Advances in Medical Sciences. 53(1). 11–6. 3 indexed citations
20.
Danila, Edvardas, et al.. (1975). [Detection of rheumatoid factors with the "rheumatoid rosette" immunocytoadherence test].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(4). 265–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026